1. Home
  2. DVAX vs HAS Comparison

DVAX vs HAS Comparison

Compare DVAX & HAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVAX
  • HAS
  • Stock Information
  • Founded
  • DVAX 1996
  • HAS 1923
  • Country
  • DVAX United States
  • HAS United States
  • Employees
  • DVAX N/A
  • HAS N/A
  • Industry
  • DVAX Biotechnology: Pharmaceutical Preparations
  • HAS Recreational Games/Products/Toys
  • Sector
  • DVAX Health Care
  • HAS Consumer Discretionary
  • Exchange
  • DVAX Nasdaq
  • HAS Nasdaq
  • Market Cap
  • DVAX 1.3B
  • HAS 11.5B
  • IPO Year
  • DVAX 2004
  • HAS N/A
  • Fundamental
  • Price
  • DVAX $9.57
  • HAS $73.92
  • Analyst Decision
  • DVAX Buy
  • HAS Strong Buy
  • Analyst Count
  • DVAX 4
  • HAS 11
  • Target Price
  • DVAX $26.50
  • HAS $85.45
  • AVG Volume (30 Days)
  • DVAX 2.0M
  • HAS 1.3M
  • Earning Date
  • DVAX 11-06-2025
  • HAS 10-23-2025
  • Dividend Yield
  • DVAX N/A
  • HAS 3.76%
  • EPS Growth
  • DVAX N/A
  • HAS N/A
  • EPS
  • DVAX N/A
  • HAS N/A
  • Revenue
  • DVAX $316,268,000.00
  • HAS $4,250,800,000.00
  • Revenue This Year
  • DVAX $23.23
  • HAS $7.56
  • Revenue Next Year
  • DVAX $16.57
  • HAS $4.81
  • P/E Ratio
  • DVAX N/A
  • HAS N/A
  • Revenue Growth
  • DVAX 26.66
  • HAS N/A
  • 52 Week Low
  • DVAX $9.20
  • HAS $49.00
  • 52 Week High
  • DVAX $14.63
  • HAS $82.19
  • Technical
  • Relative Strength Index (RSI)
  • DVAX 39.47
  • HAS 33.69
  • Support Level
  • DVAX $9.20
  • HAS $77.13
  • Resistance Level
  • DVAX $9.94
  • HAS $80.11
  • Average True Range (ATR)
  • DVAX 0.30
  • HAS 1.69
  • MACD
  • DVAX -0.04
  • HAS -0.84
  • Stochastic Oscillator
  • DVAX 31.90
  • HAS 2.18

About DVAX Dynavax Technologies Corporation

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

About HAS Hasbro Inc.

Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and since has divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022, offers the firm access to 19 million digital tabletop players.

Share on Social Networks: